--- title: "Weekly Recap | Agilent Tech +6.49%, consensus target above spot" type: "News" locale: "en" url: "https://longbridge.com/en/news/299508156.md" description: "Agilent Tech (A) advanced 6.49% this week to close at $156.47, beating the S&P 500 by roughly 6.57 percentage points. The stock opened Monday at $148, pulled back to $144.65, then climbed through the next four sessions to hit a week high of $156.89 on Thursday. Friday’s close of $156.47 came on volume of 4.85m shares, about twice the early-week pace. Daily volume averaged 35% above the 60-day median, pointing to active two-way trade during the rally." datetime: "2026-09-19T05:26:07.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/299508156.md) - [en](https://longbridge.com/en/news/299508156.md) - [zh-HK](https://longbridge.com/zh-HK/news/299508156.md) generator: "portal-rs" --- # Weekly Recap | Agilent Tech +6.49%, consensus target above spot ## The Week Agilent Tech (A) advanced 6.49% this week to close at $156.47, beating the S&P 500 by roughly 6.57 percentage points. The stock opened Monday at $148, pulled back to $144.65, then climbed through the next four sessions to hit a week high of $156.89 on Thursday. Friday’s close of $156.47 came on volume of 4.85m shares, about twice the early-week pace. Daily volume averaged 35% above the 60-day median, pointing to active two-way trade during the rally. ## Key Events The week’s news flow centred on dividends and a disclosed stake increase. On Monday, Corient Private Wealth LP reported boosting its position in Agilent. The company then announced quarterly cash dividends on Wednesday and Thursday at 25.5 cents and $0.26 per share, followed by a BRL 0.09 per-unit payout for Brazilian BDR holders on Friday. These moves fit with the roughly 0.65% dividend yield shown in the static data. The stock traded in line with Keysight and the broader sector on Friday. ## Analyst Ratings Coverage stands at 23 firms: 12 rate it buy, 4 overweight and 7 hold, with no underweight or sell ratings. The consensus rating is buy, and the consensus target of $174.95 sits about 11.81% above the latest close. Targets range from $155 to $190, a spread that suggests real disagreement on valuation. Within the life-sciences tools and services peer group, Agilent ranks 4th out of 54 companies. ## The Week Ahead No company-specific events are scheduled, so the calendar shifts to macro data. Tuesday brings the Richmond Fed composite index, Wednesday EIA crude and Cushing inventories, and Thursday jobless claims, current-account balance, new home sales and natural gas storage. Weaker macro prints could pressure sector sentiment; with the dividend now set, attention is likely to rotate toward liquidity and demand data. ## In Short This week’s price strength came alongside a mostly buy-rated analyst base and an 11.81% gap to the consensus target, but the target range spans nearly $35, so the dispersion remains wide. Valuation is mid-to-high: P/E around 30.6x and P/B about 5.99x. The latest session’s money flow showed large and medium orders as net buyers while small orders turned net sellers, a split in conviction. The question ahead is whether macro data can sustain the move or whether the volume pickup resolves into a pullback from the highs. *This article is generated by LongbridgeAI from market data, for information only and not investment advice.* ### Related Stocks - [A.US](https://longbridge.com/en/quote/A.US.md) ## Related News & Research - [Agilent (A) Stock Looks Overvalued Following Its 66% Three Year Run](https://longbridge.com/en/news/304398915.md) - [Agilent Technologies Inc. (A) Launches GC/MS System With Up to 40% Lower Energy Use](https://longbridge.com/en/news/303959822.md) - [Agilent Completes Acquisition of Proscia | A Stock News](https://longbridge.com/en/news/304291606.md) - [Agilent Technologies Announces Dividend of R$ 0.092691437 per Unit](https://longbridge.com/en/news/303618645.md) - [Compass Wealth Management LLC Acquires 17,090 Shares of Agilent Technologies, Inc. $A](https://longbridge.com/en/news/302844618.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**